Finally, our paper is out! AN7 targets all donor-HLA+ cells. Ultra-low dose + lower HSC HLA expression: hematopoiesis preserved, GVHD-suppressed. Single post-onset dose restored survival in GVHD mice. Aiming for clinical translation. x.gd/VEZbj #GVHD #HLA#Antibody
1
41
Yusuke Nak. retweeted
So glad to see this work finally out! Congrats to all that contributed both in the Thomas lab and in the @majetilab!
Dysregulated Lipid Synthesis by Oncogenic #IDH1 Mutation Is a Targetable #SyntheticLethal Vulnerability, by Daniel Thomas, @RaviMajetiMD et al.
https://teapaw.org/t.co/zrQTJERpFi
@majetilab @StanfordMed @sahmriAU @UniofAdelaide
Yusuke Nak. retweeted
Today we share in @CD_AACR unexpected metabolic differences in fatty acid metabolism between mutant IDH1 & IDH2 in AML, which we can leverage as a targetable metabolic intervention. Tremendous work by the Dan Thomas, now @UniofAdelaide. Check it out here: tinyurl.com/28kphc3f
Yusuke Nak. retweeted
The Cell Type–Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant #Preleukemia, by Nakauchi et al. https://teapaw.org/t.co/Oui8EJ2SeY
@StanfordMed
Yusuke Nak. retweeted
Just Published! The cell type specific 5hmC landscape and dynamics of healthy human hematopoiesis and TET2-mutant pre-leukemia, in this study by Nakauchi et al.
https://teapaw.org/t.co/mTjJ1f17wi
#leusm @StanfordMed
Finally our paper is out.
Humans and mice are in some ways the same and in some ways different.
The cell type specific 5hmC landscape and dynamics of healthy human hematopoiesis and TET2-mutant pre-leukemia aacrjournals.org/bloodcancer…
What should I tweet for the first time in couple of years...
Shelter-in-place order makes me fat cuz eating & drinking too much... No excuse??😱
4
I just signed up for @CopyApp and got 15 GB free online storage! #tweetFor2GBMore
copy.com/?s=twitter.usr.tour
What a shot!! -- Amazing Roger Federer trickshot on Gillette ad shoot youtube.com/watch?v=cTl3U6aS… via @youtube









